Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 23Lymphoma 16Osteosarcoma 11Lymphoma, Large B-Cell, Diffuse 11Hodgkin Disease 11Testicular Neoplasms 10Lymphoma, Non-Hodgkin 10Teratoma 8Ovarian Neoplasms 7Testicular Germ Cell Tumor 6Neuroectodermal Tumors, Primitive, Peripheral 6Neoplasms 6Burkitt Lymphoma 6Recurrence 5Endodermal Sinus Tumor 5Central Nervous System Neoplasms 5Carcinoma, Embryonal 5Lymphoma, Large-Cell, Anaplastic 4Seminoma 3Rhabdomyosarcoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Ovarian Germ Cell Cancer 3Neurofibrosarcoma 3Lymphoma, Mantle-Cell 3Lymphoma, B-Cell 3Histiocytoma, Malignant Fibrous 3Fibrosarcoma 3Vomiting 2Sarcoma, Synovial 2Sarcoma, Alveolar Soft Part 2

Interventions

Irinotecan 6Temozolomide 5Cyclophosphamide 5Vincristine 4Magnetic Resonance Spectroscopy 4Doxorubicin 4palbociclib 3X-Rays 3Phantoms, Imaging 3Gemcitabine 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2olaparib 2ivosidenib 2ganitumab 2eribulin 2cixutumumab 2cabozantinib 2abemaciclib 2Vemurafenib 2Specimen Handling 2Radiotherapy, Image-Guided 2Radiosurgery 2Peripheral Blood Stem Cell Transplantation 2Nuclear Medicine Department, Hospital 2Nivolumab 2LY3023414 2FANG vaccine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Sarcoma, Ewing × Ifosfamide × Clear all
NCT02306161 2026-06-03

Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma

National Cancer Institute (NCI)

Phase 3 Active not recruiting
312 enrolled 14 charts
Sarcoma

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡